v3.26.1
Note to Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net income $ 16,242 $ 455,555
Adjustments to reconcile net income to net cash generated from/(used in) operating activities    
Depreciation and amortization 7,072 6,118
Impairment of an intangible asset 8,941  
Share-based compensation expense-share options 971 1,552
Share-based compensation expense-LTIP 3,991 7,691
Equity in earnings of equity investees, net of tax (3,798) (23,125)
Dilution loss of investment in ImageneBio, Inc. 1,107  
Gain from divestment of equity investee   (477,456)
Dividends received from SHPL 13,343 6,987
Changes in right-of-use assets (4,187) 685
Other adjustments (1,564) 1,921
Changes in operating assets and liabilities    
Accounts receivable 9,197 8,596
Other receivables, prepayments and deposits 323 (4,943)
Amounts due from related parties (764) 204
Inventories 222 2,095
Accounts payable (11,887) 1,204
Other payables and accruals (5,202) (37,433)
Lease liabilities 3,720 (904)
Amounts due to related parties (638) 142
Deferred revenue (23,917) (22,718)
Others (949) 935
Total changes in operating assets and liabilities (29,895) (52,822)
Net cash generated from/(used in) operating activities $ 12,223 $ (72,894)